Human Genome Epidemiology Literature Finder
|
Records 1 - 12 (of 12 Records) |
| Query Trace: Hepatitis A and MDM2[original query] |
|---|
| MDM2 promoter SNP309 is associated with the risk of hepatocellular carcinoma in patients with chronic hepatitis C. Clinical cancer research : an official journal of the American Association for Cancer Research 2006 Aug 12 (16): 4867-71. Dharel Narayan, Kato Naoya, Muroyama Ryosuke, Moriyama Masaru, Shao Run-Xuan, Kawabe Takao, Omata Mas |
| MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Carcinogenesis 2008 Jun 29 (6): 1192-6. Yoon Young Joon, Chang Hye Young, Ahn Sang Hoon, Kim Ja Kyung, Park Yong Kwang, Kang Dae Ryong, Park Jun Yong, Myoung Sung Min, Kim Do Young, Chon Chae Yoon, Han Kwang-Hy |
| Association between MDM2-SNP309 and hepatocellular carcinoma in Taiwanese population. World journal of gastroenterology : WJG 2009 Nov 15 (44): 5592-7. Leu Jyh-Der, Lin I-Feng, Sun Ying-Fang, Chen Su-Mei, Liu Chih-Chao, Lee Yi-Ja |
| TP53 and MDM2 gene polymorphisms and risk of hepatocellular carcinoma among Italian patients. Infectious agents and cancer 2011 6 (1): 13. Di Vuolo Valeria, Buonaguro Luigi, Izzo Francesco, Losito Simona, Botti Gerardo, Buonaguro Franco M, Tornesello Maria Li |
| Genetic risk of hepatocellular carcinoma in patients with hepatitis C virus: a case control study. Journal of gastroenterology and hepatology 2012 Apr 27 (4): 797-804. Tomoda Takeshi, Nouso Kazuhiro, Sakai Akiko, Ouchida Mamoru, Kobayashi Sayo, Miyahara Koji, Onishi Hideki, Nakamura Shinichiro, Yamamoto Kazuhide, Shimizu Ken |
| MDM2 SNP309T>G polymorphism increases susceptibility to hepatitis B virus-related hepatocellular carcinoma in a northeast Han Chinese population. Liver international : official journal of the International Association for the Study of the Liver 2012 Aug 32 (7): 1172-8. Wang Xi, Zhang Xuelong, Qiu Bing, Tang Yinhua, Sun He, Ji Hongfei, Liu Yan, Shi Lijun, Song Guang, Yang Youl |
| Correlation of TP53 mutations with HCV positivity in hepatocarcinogenesis: identification of a novel TP53 microindel in hepatocellular carcinoma with HCV infection. Oncology reports 2013 Jul 30 (1): 119-24. Long Jiang, Wang Yan, Li Man, Tong Wei-Min, Jia Ji-Dong, Huang Ji |
| Combined effects of p53 and MDM2 polymorphisms on susceptibility and surgical prognosis in hepatitis B virus-related hepatocellular carcinoma. Protein & cell 2013 Jan 4 (1): 1. Yang Y, Xia T, Li N, Zhang J, Yang Y, Cong W, Deng Q, Lan K, Zhou W |
| Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing. Oncotarget 2014 May 5 (10): 3012-22. Janku Filip, Kaseb Ahmed O, Tsimberidou Apostolia M, Wolff Robert A, Kurzrock Razel |
| TP53 and MDM2 gene polymorphisms, gene-gene interaction, and hepatocellular carcinoma risk: evidence from an updated meta-analysis. PloS one 2013 8 (12): e82773. Peng Qiliu, Lao Xianjun, Chen Zhiping, Lai Hao, Deng Yan, Wang Jian, Mo Cuiju, Sui Jingzhe, Wu Junrong, Zhai Limin, Yang Shi, Qin Xue, Li Sh |
| Interaction between p53 codon 72 and MDM2 309T>G polymorphisms and the risk of hepatocellular carcinoma. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015 Oct . Qiu Moqin, Liu Yingchun, Yu Xiangyuan, Qin Linyuan, Bei Chunhua, Zeng Xiaoyun, Qiu Xiaoqiang, Tang Bo, He Songqing, Yu Hongpi |
| Germline Duplication of SNORA18L5 Increases Risk for HBV-related Hepatocellular Carcinoma by Altering Localization of Ribosomal Proteins and Decreasing Levels of p53. Gastroenterology 2018 4 155 (2): 542-556. Cao Pengbo, Yang Aiqing, Wang Rui, Xia Xia, Zhai Yun, Li Yuanfeng, Yang Fei, Cui Ying, Xie Weimin, Liu Ying, Liu Taotao, Jia Weihua, Jiang Zhengwen, Li Zhuo, Han Yuqing, Gao Chengming, Song Qingfeng, Xie Bobo, Zhang Luo, Zhang Hongxing, Zhang Jinxu, Shen Xizhong, Yuan Yunfei, Yu Feng, Wang Ying, Xu Jing, Ma Yilong, Mo Zengnan, Yu Wuzhong, He Fuchu, Zhou Gangqi |
- Page last reviewed:Feb 1, 2024
- Content source: